Latest Headlines

• 

  Ligand Pharmaceuticals Incorpor Earnings: Your Sneak Peek to the Big Announcement

  Derek Hoffman   | Tue, May 7 |  Comment
• 

  Nomura Loses Executive to BofA and 3 Stocks At 52-Week Highs

  Mark Lawson   | Fri, Mar 15 |  Comment
• 

  Microsoft Downgraded to Hold and 4 Downgraded Stocks to Eye

  Alex Capel   | Fri, Jan 4 |  Comment
• 

  Wright & BioMimetic Merge, GlaxoSmithKline Gets Promacta Approval: Healthcare Biz Update

  Mark Lawson   | Tue, Nov 20 |  Comment
• 

  Will Ligand's Partner's FDA Approval Make These Top Institutional Shareholders Feel Better?

  Deann Marin   | Mon, Nov 19 |  Comment
• 

  Facebook Scoffs at Yahoo Rumor and 4 Hot Stocks Making Market Waves

  Leah Powell   | Mon, Nov 19 |  Comment
• 

  Medifast Reiterated at Outperform and 4 Analyst-Reiterated Ratings to Know Now

  Alex Capel   | Tue, Nov 6 |  Comment
• 

  Ligand Revenues Aided by Kyprolis and 4 Must-See Stock Analyses

  Leah Powell   | Mon, Nov 5 |  Comment
• 

  Healthcare Business Update: Merck Pays Milestone to Ligand, Alnylam Partners with Genzyme

  Mark Lawson   | Mon, Oct 22 |  Comment
• 

  EA WELL POSITIONED for Remaining 2012 Title Releases and 4 Stock Analyses Making the Rounds

  Leah Powell   | Thu, Sep 6 |  Comment
• 

  Netflix REITERATED Below Average and 3 Analyst-Reiterated Ratings Starting the Week

  Emily Jones   | Mon, Jul 23 |  Comment
• 

  Healthcare Business Recap: Onyx's Drug Gets APPROVED, Somaxon DIVESTS Shares

  Mark Lawson   | Fri, Jul 20 |  Comment